Günter Graubach
Executive Chairman of Curatis and previously Curatis' Chief Executive Officer (until 2011); held various commercial management positions at Speciality European Pharma (now Contura), MyoContract (now Santhera Pharmaceuticals) and Hoffmann-La Roche in Switzerland, USA, and Latin America. Mr Graubach holds a Maîtrise AES in Business from the University of Lyon, France and a lic.oec.int in International Economic Relations from the University of Constance, Germany.